🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 10 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/03/2017 | 66,77 | 67,90 | 66,77 | 67,69 | +1,48% | 1,69% | 384.560 |
| 08/03/2017 | 66,09 | 67,14 | 65,53 | 66,70 | +0,93% | 2,43% | 374.942 |
| 07/03/2017 | 65,32 | 66,38 | 64,95 | 66,08 | +0,16% | 2,19% | 381.354 |
| 06/03/2017 | 64,44 | 66,12 | 63,94 | 65,98 | +2,04% | 3,39% | 861.452 |
| 03/03/2017 | 63,63 | 65,41 | 63,63 | 64,66 | +1,66% | 2,80% | 803.584 |
| 02/03/2017 | 64,14 | 64,86 | 63,28 | 63,61 | -1,15% | 2,47% | 802.622 |
| 01/03/2017 | 66,14 | 66,73 | 63,63 | 64,35 | -1,41% | 4,69% | 631.101 |
| 28/02/2017 | 66,91 | 67,34 | 65,03 | 65,27 | -2,56% | 3,45% | 974.464 |
| 27/02/2017 | 63,06 | 67,34 | 61,94 | 66,99 | +6,97% | 8,56% | 1.586.810 |
| 24/02/2017 | 61,14 | 62,68 | 59,31 | 62,62 | -2,39% | 5,51% | 1.203.532 |
| 23/02/2017 | 64,53 | 64,83 | 62,43 | 64,15 | -0,42% | 3,71% | 661.398 |
| 22/02/2017 | 65,61 | 65,61 | 64,01 | 64,42 | -1,94% | 2,44% | 369.492 |
| 21/02/2017 | 66,11 | 66,44 | 64,66 | 65,70 | -0,38% | 2,70% | 281.807 |
| 17/02/2017 | 65,52 | 66,79 | 64,50 | 65,95 | +0,36% | 3,48% | 376.545 |
| 16/02/2017 | 65,05 | 65,80 | 63,83 | 65,71 | +1,01% | 3,03% | 427.520 |
| 15/02/2017 | 63,62 | 65,46 | 62,98 | 65,05 | -2,56% | 3,90% | 892.550 |
| 14/02/2017 | 66,75 | 66,92 | 66,32 | 66,76 | -0,12% | 0,90% | 373.980 |
| 13/02/2017 | 67,06 | 67,12 | 66,56 | 66,84 | +0,20% | 0,83% | 306.975 |
| 10/02/2017 | 67,56 | 67,56 | 66,68 | 66,71 | -0,97% | 1,30% | 382.796 |
| 09/02/2017 | 66,96 | 68,60 | 66,96 | 67,37 | +0,64% | 2,44% | 401.872 |
| 08/02/2017 | 66,77 | 67,60 | 66,24 | 66,94 | -0,50% | 2,04% | 211.436 |
| 07/02/2017 | 67,19 | 68,00 | 66,11 | 67,27 | +0,08% | 2,81% | 348.011 |
| 06/02/2017 | 66,83 | 67,50 | 66,51 | 67,22 | +0,18% | 1,49% | 222.657 |
| 03/02/2017 | 65,00 | 67,31 | 64,62 | 67,10 | +3,44% | 4,14% | 386.323 |
| 02/02/2017 | 66,22 | 66,22 | 64,36 | 64,87 | -1,90% | 2,81% | 466.794 |
| 01/02/2017 | 66,23 | 66,73 | 65,60 | 66,12 | -0,02% | 1,70% | 368.530 |
| 31/01/2017 | 62,71 | 66,44 | 62,71 | 66,13 | +4,82% | 5,96% | 506.548 |
| 30/01/2017 | 63,68 | 63,77 | 62,74 | 63,09 | -1,53% | 1,61% | 291.586 |
| 27/01/2017 | 64,46 | 64,98 | 63,76 | 64,07 | -0,34% | 1,89% | 253.915 |
| 26/01/2017 | 64,62 | 65,01 | 64,13 | 64,29 | -0,34% | 1,36% | 307.455 |